Litcius/Paper detail

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease

Jan Zuna, Lenka Hovorková, Justina Krotka, Amelie Koehrmann, Michela Bardini, Lucie Winkowska, Eva Froňková, Julia Alten, Rolf Koehler, Cornelia Eckert, Lisa Brizzolara, Marie Trková, Jan Stuchlý, Martin Zimmermann, Paola De Lorenzo, Maria Grazia Valsecchi, Valentino Conter, Jan Starý, Martin Schrappe, Andrea Biondi, Jan Trka, Markéta Žaliová, Giovanni Cazzaniga, Gunnar Cario

2022Leukemia61 citationsDOI

Topics & Concepts

Minimal residual diseaseMedicineOncologyInternal medicineMyeloid leukemiaDiseasebreakpoint cluster regionChemotherapyABLLeukemiaImmunologyTyrosine kinaseReceptorAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia Research
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Litcius